Top Markets
Coin of the day
Eikon Therapeutics, Inc. Common Stock Eikon Therapeutics, Inc. Common Stock

Eikon Therapeutics, Inc. Common Stock

EIKN
Clasificación en acciones #12325
Eikon Therapeutics, Inc. is a clinical biopharmaceutical company, established... Eikon Therapeutics, Inc. is a clinical biopharmaceutical company, established in 2019 and headquartered in Millbrae, California, operating within the United States. The company is dedicated to developing groundbreaking medicines to address significant unmet medical needs. It utilizes a proprietary platform capable of precisely characterizing protein interactions inside living cells. Eikon's drug pipeline includes EIK1001, a systemically delivered TLR 7/8 dual-agonist designed to activate both innate and adaptive anti-cancer immune responses; EIK1003 and EIK1004, which are selective PARP1 inhibitors for ovarian, breast, prostate, and pancreatic cancers. Notably, EIK1004 is brain-penetrant, offering a therapeutic approach for brain metastases and primary brain malignancies. Additionally, EIK1005 is a potent WRN helicase inhibitor and anti-tumor agent aimed at MSI-high tumors, alongside EIK1006.
Precio por acción
$11.03
Última sincronización: 2026-08-28
Capitalización bursátil
$597.15M
Cambio (1 día)
-4.25%
Cambio (1 año)
-
País
US
Comercio Eikon Therapeutics, Inc. Common Stock (EIKN)

Categoría

Historial de desdoblamientos de acciones de Eikon Therapeutics, Inc. Common Stock (EIKN)
La acción Eikon Therapeutics, Inc. Common Stock (símbolo: EIKN) tuvo un total de 0 desdoblamientos.
El desdoblamiento más reciente ocurrió el Aug 31, 2026.
Una acción EIKN comprada antes de Aug 31, 2026 equivaldría hoy a 0 acciones EIKN.
Lista de desdoblamientos de acciones
Año Desdoblamiento Multiplicador Multiplicador acumulado
Not enough data for the provided dates.
Desdoblamientos de acciones de empresas similares o competidoras
Empresa Número de desdoblamientos de acciones Multiplicador acumulado País
1 x2
US
0 -
NL
1 x3
AU
0 -
US
0 -
CH